Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RFUS-949 for postoperative analgesia after abdominal surgery
ChiCTR2600134647Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of RFUS-949 in postoperative pain (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: PGIC score, Proportion of participants with at least 30%, 50%, and 70% reduction in NRS pain score and 11 more. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
RFUS-949
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600134647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134647.